Literature DB >> 9238509

NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.

P A Baeuerle1, V R Baichwal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9238509

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  131 in total

1.  Cellular handling of a dexamethasone-anti-E-selectin immunoconjugate by activated endothelial cells: comparison with free dexamethasone.

Authors:  Robbert J Kok; Maaike Everts; Sigridur A Asgeirsdóttir; Dirk K F Meijer; Grietje Molema
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

2.  Mutant human cells with constitutive activation of NF-kappaB.

Authors:  Swati S Sathe; Nywana Sizemore; Xiaoxia Li; Kalpa Vithalani; Mairead Commane; Shannon M Swiatkowski; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

3.  Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease.

Authors:  JoAnn P Palma; Daeho Kwon; Neil A Clipstone; Byung S Kim
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

4.  Computationally identifying novel NF-kappa B-regulated immune genes in the human genome.

Authors:  Rongxiang Liu; Richard C McEachin; David J States
Journal:  Genome Res       Date:  2003-03-12       Impact factor: 9.043

Review 5.  Nuclear factor (NF)-kappaB proteins: therapeutic targets.

Authors:  I M Verma
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

6.  Tumor necrosis factor-α represses the expression of NHE2 through NF-κB activation in intestinal epithelial cell model, C2BBe1.

Authors:  Md Ruhul Amin; Temitope Orenuga; Sangeeta Tyagi; Pradeep K Dudeja; Krishnamurthy Ramaswamy; Jaleh Malakooti
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

7.  Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes.

Authors:  Sunil K Manna; Shubhashish Sarkar; Johnny Barr; Kimberly Wise; Enrique V Barrera; Olufisayo Jejelowo; Allison C Rice-Ficht; Govindarajan T Ramesh
Journal:  Nano Lett       Date:  2005-09       Impact factor: 11.189

8.  Inhibition of PMA-induced endothelial cell activation and adhesion by over-expression of domain negative IkappaBalpha protein.

Authors:  Jian-Feng Wei; Ke Sun; Shi-Guo Xu; Hai-Yang Xie; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

9.  Childhood nephrotic syndrome in relapse is associated with down-regulation of monocyte CD14 expression and lipopolysaccharide-induced tumour necrosis factor-alpha production.

Authors:  S P Chen; W Cheung; C K Heng; S C Jordan; H K Yap
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

10.  A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.

Authors:  Karl Ziegelbauer; Florian Gantner; Nicholas W Lukacs; Aaron Berlin; Kinji Fuchikami; Toshiro Niki; Katsuya Sakai; Hisayo Inbe; Keisuke Takeshita; Mina Ishimori; Hiroshi Komura; Toshiki Murata; Timothy Lowinger; Kevin B Bacon
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.